Literature DB >> 2824265

Factors affecting the infection of the D variant of encephalomyocarditis virus in the B cells of C57BL/6J mice.

K L Gaines1, S G Kayes, G L Wilson.   

Abstract

The D variant of encephalomyocarditis virus is capable of infecting most inbred strains of mice. However, only certain strains are susceptible to the diabetogenic effect of this virus. In order to understand why some inbred strains do not become diabetic, the pathogenesis of infection was studied in diabetes-resistant C57BL/6J mice. It was the purpose of the investigation to ascertain whether specific host defense factors might play a crucial role in the mechanism of resistance. To determine whether perturbations of the immune response would alter the resistance of these animals, mice were treated with a high dose (1.15 mmol/kg body weight) of the T- and B-cell toxin cyclophosphamide prior to infection with the D variant. This treatment did not induce overt diabetes or glucose intolerance in the mice tested 7 days after infection. Based on this finding, it appeared likely that resistance to the D variant is conveyed by some factor other than cell-mediated immunity. A likely candidate to control this viral infection is the interferon system. To investigate this possibility, C57BL/6J mice were infected with the D variant and the concentrations of serum interferon titred at various intervals thereafter. In contrast to previous reports with diabetes susceptible mice, C57BL/6J mice were found to generate a substantial interferon response against this variant, with peak levels found in the serum at 24 h following infection. Additional studies were performed in which mice were treated with antibody to mouse interferon alpha/beta at the time of infection and again 3 days after infection with the D variant.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824265     DOI: 10.1007/BF00292545

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Virus-induced diabetes in mice: a quantitative evaluation of islet cell population by immunofluorescence technique.

Authors:  Y Stefan; F Malaisse-Lagae; J W Yoon; A L Notkins; L Orci
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

2.  Interferon structural genes do not participate in quantitative regulation of interferon production by If loci as shown in C57BL/6 mice that are congenic with BALB/c mice at the alpha interferon gene cluster.

Authors:  J De Maeyer-Guignard; F Dandoy; D W Bailey; E De Maeyer
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Pathogenicity of the M and E variants of the encephalomyocarditis (EMC) virus. I. Myocardiotropic and neurotropic properties.

Authors:  J E Craighead
Journal:  Am J Pathol       Date:  1966-02       Impact factor: 4.307

4.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

5.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

6.  Altered pathogenesis in encephalomyocarditis virus (D variant)-infected diabetes-susceptible and resistant strains of mice.

Authors:  K L Gaines; S G Kayes; G L Wilson
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

7.  Spleen cell responses in experimental murine toxocariasis.

Authors:  S G Kayes
Journal:  J Parasitol       Date:  1984-08       Impact factor: 1.276

8.  Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta-cells by the D-variant of encephalomyocarditis virus.

Authors:  J W Yoon; P R McClintock; C J Bachurski; J D Longstreth; A L Notkins
Journal:  Diabetes       Date:  1985-09       Impact factor: 9.461

9.  Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.

Authors:  J W Yoon; P R McClintock; T Onodera; A L Notkins
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Virus-induced diabetes mellitus. I. Hyperglycemia and hypoinsulinemia in mice infected with encephalomyocarditis virus.

Authors:  D W Boucher; A L Notkins
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  3 in total

1.  Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon.

Authors:  Y H Su; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Effects of type I interferons on Friend retrovirus infection.

Authors:  Nicole Gerlach; Simone Schimmer; Siegfried Weiss; Ulrich Kalinke; Ulf Dittmer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Innate immune response to encephalomyocarditis virus infection mediated by CD1d.

Authors:  Mark A Exley; Nancy J Bigley; Olivia Cheng; Angela Shaulov; Syed Muhammad Ali Tahir; Quincy L Carter; Jorge Garcia; Carren Wang; Kurt Patten; Harold F Stills; Frederick W Alt; Scott B Snapper; Steven P Balk
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.